What We Treat

Traumatic Brain Injury

Traumatic brain injury is characterized by altered consciousness or loss of consciousness with varying severities of injury (mild, moderate, or severe) that are proportional to the force of injury and cause anywhere from temporary neurologic dysfunction to death. Up to 55% of all mild TBI patients develop the persistent post-concussion syndrome characterized by cognitive symptoms, headache, irritability, sleep disruption, fatigue, dizziness, depression, anxiety, apathy, and change in personality.

HBOT is the only therapy that directly treats the underlying disease processes of TBI (decreased oxygen, decreased blood flow, swelling of the brain, constriction of blood vessels, acidosis, anaerobic metabolism). HBOT has been shown in multiple studies to have the greatest reduction in mortality of any therapy.

One to three sessions of HBOT in the acute period can decrease the mortality by 50-60% There is very little published experience of HBOT in mild TBI, but in Dr. Harch’s career he has treated many patients within the first week after concussion/mild TBI. With mild TBI after just a few treatments, many patients experience near complete or complete relief of symptoms. For patients with the persistent post-concussion syndrome, HBOT is the most effective therapy known. HBOT is effective in relieving symptoms brain related combat injuries and can create a reduction in suicide ideation in veterans.

source
The Oxygen Rev. Dr.Harch

Stroke

Benefits from HBOT

There are a wide range of benefits, but the treatment of hbot have resulted in patients generally experiencing partial or complete reversal of the neurologicaldeficit. The most important factor in HBOT treatment of stroke has been the proper dosing of HBOT, based on the type of stroke, and time of intervention. While the best results are derived from early application of HBOT, most patients don’t get HBOT until years after their stroke.

Even in these chronic cases, which comprise the bulk of stroke patients can still experience improvement in their motor, sensory, cognitive, gait, balance, and other symptoms. One of the most comprehensive reviews of HBOT in stroke is presented by Dr. Jain in the Textbook of Hyperbaric Medicine. The net result of all studies and the treatment of over 2000 stroke patients is a beneficial effect of HBOT on all phases of stroke.

Source
The Oxygen Rev. Dr.Harch,
Textbook of Hyperbaric Med. K.K. Jain. M.D.

Autism (ASD)

Autism or Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental disorders that are defined by behavioral observations and are characterized by impairments in communication and social interaction along with restrictive and repetitive behaviors [31]. ASD includes autistic disorder, Asperger syndrome, and pervasive developmental disorder-not otherwise specified (PDD-NOS). An estimated 1 out of 110 individuals in the United States is currently affected with an ASD……

Recently, hyperbaric oxygen therapy (HBOT) has increased in popularity as a treatment for autism. Numerous studies document oxidative stress and inflammation in individuals with autism; both of these conditions have demonstrated improvement with HBOT, along with enhancement of neurological function and cognitive performance. Children with autism were treated with HBOT at atmospheric pressures and oxygen concentrations in current use for this condition. Changes in markers of oxidative stress and inflammation were measured. The children were evaluated to determine clinical effects and safety.

Pre- and post-parental observations indicated statistically significant improvements in both groups, including motivation, speech, and cognitive awareness (p < 0.05). No major adverse events were observed.

Source
Rossignol, D.A., Rossignol, L.W., James, S.J. et al

It has been demonstrated that the majority of patients affected by ASD (Autism Spectrum Disorder) have high levels of inflammation, compromised blood flow and low oxygen delivery to certain parts of the body. HBOT has been shown in clinical data to help decrease inflammation and reintroduce oxygen and blood flow to affected areas, including affected regions in the brain. This has demonstrated to help improve overall functioning, receptive language, speech and eye contact scores. Additionally, it has been shown to help decrease irritability, hyperactivity and inflammatory markers including TNF-alpha and C-reactive protein levels.

Completing a minimum of 40 hours of therapy within 30 days is the most highly recommended protocol for HBOT, regardless of the pressure. This recommendation parallels clinical data and directly correlates to the best results that have been seen and recorded.

Multiple Sclerosis

HBOT works in MS by repairing the wounds to the nerve fibers and inhibiting inflammation. Benefits from HBOToften include increased mobility, reduced fatigue, and improved equilibratory coordination. Urinary symptoms also improve, as well as nystagmus and spasticity. The most rigorous study ever performed using HBOT-treatment of MS was published in one of the most prestigious medical journals, the New England Journal of Medicine, in 1983.

The study showed a statistically significant improvement in HBOT-treated MS patients compared to the control group. Patients experienced increased mobility, reduced fatigability, and improved equilibratory coordination, along with improved urinary symptoms, improvements in nystagmus (rapid beating of the eyes), and improvements in spasticity. At the one year follow-up, deterioration occurred in 12% of the HBOT group vs. 55% of the control group. In other words, HBOT had a sustained effect and prevented further deterioration.

When ten to fourteen year follow-up studies were performed on MS patients in England receiving long-term treatment (one treatment every 2-4 weeks) patients demonstrate maintenance and even improvement in neurological function.

Source
Dr.Paul Harch.

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Porro minima molestiae maiores reprehenderit dolorem placeat, distinctio non labore debitis beatae. Necessitatibus, esse fugit accusantium veniam dolor sint quod labore magni.Lorem ipsum dolor sit amet, consectetur adipisicing elit. Porro minima molestiae maiores reprehenderit dolorem placeat, distinctio non labore debitis beatae. Necessitatibus, esse fugit accusantium veniam dolor sint quod labore magni.Lorem ipsum dolor sit amet, consectetur adipisicing elit. Porro minima molestiae maiores reprehenderit dolorem placeat, distinctio non labore debitis beatae. Necessitatibus, esse fugit accusantium veniam dolor sint quod labore magni.

Traumatic Brain Injury

source
The Oxygen Rev. Dr.Harch

Stroke

Benefits from HBOT

Source
The Oxygen Rev. Dr.Harch,
Textbook of Hyperbaric Med. K.K. Jain. M.D.

Autism (ASD)

Source
Rossignol, D.A., Rossignol, L.W., James, S.J. et al

Multiple Sclerosis

Source
Dr.Paul Harch.

Make an Appointment

Disclaimer

What We Treat

Traumatic Brain Injury

source The Oxygen Rev. Dr.Harch

Stroke

Benefits from HBOT

Source The Oxygen Rev. Dr.Harch, Textbook of Hyperbaric Med. K.K. Jain. M.D.

Autism (ASD)

Source Rossignol, D.A., Rossignol, L.W., James, S.J. et al

Multiple Sclerosis

Source Dr.Paul Harch.

Make an Appointment

Disclaimer

source
The Oxygen Rev. Dr.Harch

Source
The Oxygen Rev. Dr.Harch,
Textbook of Hyperbaric Med. K.K. Jain. M.D.

Source
Rossignol, D.A., Rossignol, L.W., James, S.J. et al

Source
Dr.Paul Harch.